z-logo
open-access-imgOpen Access
Functional evolution of visual involvement in experimental autoimmune encephalomyelitis
Author(s) -
Silvia Marenna,
SuChun Huang,
Valerio Castoldi,
Raffaele d’Isa,
Gloria Dalla Costa,
Gıancarlo Comı,
Letizia Leocani
Publication year - 2020
Publication title -
multiple sclerosis journal - experimental translational and clinical
Language(s) - English
Resource type - Journals
ISSN - 2055-2173
DOI - 10.1177/2055217320963474
Subject(s) - experimental autoimmune encephalomyelitis , multiple sclerosis , optic neuritis , optic nerve , myelin oligodendrocyte glycoprotein , medicine , neuroscience , encephalomyelitis , pathology , ophthalmology , immunology , biology
Background Experimental autoimmune encephalomyelitis (EAE) is a common animal model of multiple sclerosis (MS). C57BL/6 mice immunized with myelin oligodendrocyte glycoprotein exhibit chronic disease course, together with optic neuritis, consisting of demyelination/axonal loss of the optic nerve.Objectives To characterize functional and structural visual damages in two different phases of EAE: pre- and post-motor onset.Methods Visual alterations were detected with Visual Evoked Potential (VEP), Electroretinogram (ERG) and Optical Coherence Tomography (OCT). Optic nerve histology was performed at 7 (pre-motor onset) or 37 (post-motor onset) days post-immunization (dpi).Results At 7 dpi, optic nerve inflammation was similar in EAE eyes with and without VEP latency delay. Demyelination was detected in EAE eyes with latency delay (p < 0.0001), while axonal loss (p < 0.0001) and ERG b-wave amplitude (p = 0.004) were decreased in EAE eyes without latency delay compared to Healthy controls. At 37 dpi, functional and structural optic nerve damage were comparable between EAE groups, while a decrease of ERG amplitude and NGCC thickness were found in EAE eyes with VEP latency delay detected post-motor onset.Conclusions Thanks to non-invasive methods, we studied the visual system in a MS model, which could be useful for developing specific therapeutic strategies to target different disease phases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom